Johan Seijsing
Chief Technology Officer at Thioredoxin Systems AB- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
-
Swedish Native or bilingual proficiency
-
English Full professional proficiency
-
Spanish Elementary proficiency
-
German Elementary proficiency
Topline Score
Bio
Experience
-
Thioredoxin Systems AB
-
Sweden
-
Biotechnology Research
-
1 - 100 Employee
-
Chief Technology Officer
-
Apr 2022 - Present
-
-
-
Selenozyme
-
Sweden
-
Biotechnology
-
Laboratory Manager
-
Mar 2022 - Present
Protein production, purification and characterization. Protein production, purification and characterization.
-
-
-
BioArctic
-
Biotechnology Research
-
1 - 100 Employee
-
Scientist
-
Sep 2020 - Sep 2021
Protein expression, purification and characterization. Bioassays. Supporting the protein engineering department with theoretical knowledge. Protein expression, purification and characterization. Bioassays. Supporting the protein engineering department with theoretical knowledge.
-
-
-
Spiber Technologies AB
-
Sweden
-
Biotechnology Research
-
1 - 100 Employee
-
Researcher
-
Oct 2019 - Mar 2020
-
-
-
Stockholm University
-
Sweden
-
Research Services
-
700 & Above Employee
-
Researcher
-
Jan 2018 - Jun 2019
Development of protein-based antimicrobials.
-
-
Postdoctoral Researcher
-
Mar 2016 - Jan 2018
Development of protein-based antimicrobials.
-
-
-
ETH Zürich
-
Switzerland
-
Higher Education
-
700 & Above Employee
-
Postdoctoral Researcher
-
Aug 2015 - Mar 2016
Development of protein-based antimicrobials. Development of protein-based antimicrobials.
-
-
-
KTH Royal Institute of Technology
-
Sweden
-
Higher Education
-
700 & Above Employee
-
Researcher
-
Jun 2015 - Jul 2015
The Drug Discovery and Development Platform at SciLifeLab The Drug Discovery and Development Platform at SciLifeLab
-
-
-
KTH Royal Institute of Technology
-
Sweden
-
Higher Education
-
700 & Above Employee
-
Postdoctoral Researcher
-
May 2014 - Apr 2015
Development of protein-based antimicrobials.
-
-
PhD student - Molecular biotechnology, gene therapy and protein engineering
-
Jan 2010 - May 2014
Development of a FcRn inhibitor that is currently in Phase I clinical trials. Development of a serum circulation half-life extension technology for therapeutical proteins. Development of targeted lentiviral gene therapy vectors. Development of artificial zinc finger transcription factors.
-
-
-
-
Scholarship holder - Gene therapy vectors
-
Sep 2009 - Dec 2009
-
-
-
Human Proteome Atlas
-
Stockholm, Sweden
-
Laboratory technician - Cell Profiling
-
Jun 2008 - Dec 2008
-
-
-
Human Proteome Atlas
-
Stockholm, Sweden
-
Laboratory technician - Protein Factory
-
Jun 2007 - Aug 2007
-
-
-
IDG (International Data Group)
-
United States
-
Advertising Services
-
500 - 600 Employee
-
Journalist / Freelance writer
-
Mar 2006 - Oct 2006
-
-
-
Various
-
Stockholm, Sweden
-
Shop assistant
-
Jan 2001 - Aug 2005
-
-
Education
-
KTH Royal Institute of Technology
Master of Science (MSc), Civil engineer in molecular biotechnology -
Karolinska institutet
Mixed courses during my PhD -
Universidad Politécnica de Valencia
Exchange student, Biotechnology and Spanish language -
Kärrtorps gymnasium
Gymnasium, Natural Sciences -
STING